Evidence map›Paper›PMID 28662241›Full record

ArticleJournal of biomedical optics2017

Ultrafast laser-assisted spatially targeted optoporation into cortical axons and retinal cells in the eye.

Subrata Batabyal, Young-Tae Kim, Samarendra Mohanty

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Subrata BatabyalNanoScope Technologies LLC, Bedford, Texas, United States.
Young-Tae KimUniversity of Texas at Arlington, Department of Bioengineering, Texas, United States.
Samarendra MohantyNanoScope Technologies LLC, Bedford, Texas, United States.
The University of Texas at Arlington · US

Funding

Broad-band opsin and targeted optical-delivery for retinitis pigmentosa treatmentR01EY025717 · NEI · NANOSCOPE TECHNOLOGIES, LLC · PI MOHANTY, SAMARENDRA KUMAR · 2016 to 2020
$1.7M
All optical control and monitoring of neural activityR21NS084311 · NINDS · UNIVERSITY OF TEXAS ARLINGTON · PI DAVE, DIGANT P · 2013 to 2014
$382k
NEI NIH HHS R01 EY025717NINDS NIH HHS R21 NS084311
6 · The paper itself

Abstract

Visualization and assessment of the cellular structure and function require localized delivery of the molecules into specific cells in restricted spatial regions of the tissue and may necessitate subcellular delivery and localization. Earlier, we have shown ultrafast near-infrared laser beam-assisted optoporation of actin-staining molecules into cortical neurons with single-cell resolution and high efficiency. However, diffusion of optoporated molecules in soma degrades toward the growth cone, leading to difficulties in visualization of the actin network in the growth cone in cases of long axons. Here, we demonstrate optoporation of impermeable molecules to functional cortical neurons by precise laser subaxotomy near the growth cone, leading to visualization of the actin network in the growth cone. Further, we demonstrate patterned delivery of impermeable molecules into targeted retinal cells in the rat eye. The development of optoporation as a minimally invasive approach to reliably deliver exogenous molecules into targeted axons and soma of retinal neurons in vivo will enable enhanced visualization of the structure and function of the retina.

Indexed as

LasersAnimalsAxonsCytological TechniquesNeuronsRatsRetina

Identifiers

PMID28662241
PMCPMC5490686
OpenAlexW2724950218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.